Related Experiment Video
Updated: May 28, 2026

09:37
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL
Hisataka Goto1, Akira Hozumi, Makoto Osaki
1Department of Orthopaedic Surgery, Graduate School of Biomedical Science, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Cytokine
|October 4, 2011
Summary
Tumor necrosis factor-alpha (TNF-α) boosts Receptor Activator of Nuclear factor κ-B Ligand (RANKL) in bone marrow cells. This enhances osteoclast differentiation, potentially impacting osteoporosis.
Area of Science:
- Bone Biology
- Cellular Biology
- Immunology
Background:
- Bone marrow adipocytes are implicated in steroid osteoporosis via Receptor Activator of Nuclear factor κ-B Ligand (RANKL) induced osteoclastogenesis.
- Understanding the role of inflammatory cytokines in this process is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of Tumor necrosis factor-alpha (TNF-α) on RANKL expression in human bone marrow adipocytes.
- To evaluate the capacity of TNF-α-treated bone marrow adipocytes to support osteoclast differentiation.
Main Methods:
- Real-time RT-PCR was used to quantify mRNA expression of RANKL, osteoprotegerin (OPG), and macrophage-colony stimulating factor (M-CSF) in bone marrow adipocytes.
- Co-culture systems of bone marrow adipocytes and osteoclast precursors were established with or without TNF-α to assess osteoclast differentiation morphologically and functionally.
Main Results:
- TNF-α treatment significantly increased RANKL expression and the RANKL/OPG ratio in bone marrow adipocytes.
- Co-cultures with TNF-α showed increased TRAP-positive multinuclear cells and resorption activity, indicating enhanced osteoclast differentiation.
- Osteoclast differentiation was inhibited by anti-RANKL antibody, confirming the mechanism's dependence on RANKL.
Conclusions:
- TNF-α upregulates RANKL expression in primary human bone marrow adipocytes.
- Bone marrow adipocytes treated with TNF-α promote osteoclast differentiation and activity, mediated by increased RANKL expression.
Related Concept Videos
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Cells and Tissue
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

